IIIN Q1 2026 Earnings EPS Misses Estimates Despite Stock Uptick Woodward WWD Q1 2026 Earnings EPS Surpasses Estimates by 782 Stock Edges Lower REYN Q1 2026 Earnings EPS Surpasses Estimates by 136 Revenue Not Disclosed XPEL Q1 2026 Earnings Modest EPS Beat Amid Quiet Revenue Disclosure Atea Pharmaceuticals Q1 2026 Earnings Narrower Loss Beats Expectations Stock Edges Higher Iovance Biotherapeutics Q1 2026 Earnings EPS Misses Estimates but Stock Rises on Operational Momentum